Healthtech funding in H2 2022
European Healthtech startup funding raised during H2 2022.
In H2 2022, 308 European Healthtech companies closed 327 funding rounds and raised €3.5B in equity funding (excluding debt and grants), down 39.7% versus H2 2021. Debt rounds added €624M. UK led by capital raised, and Bpifrance was the most active investor. Data as of 20 Nov 2026.
Equity funding
€3.5B
-39.7% vs H2 2021 · excl. debt & grants · +€624M debt
Funding rounds
327
-13.0% vs H2 2021
Companies
308
Top country
UK
Rank among sectors
#4
9.4% of sector funding
Debt financing
€624M
15.1% of total
Top-10 round share
32.4%
of disclosed capital
Rounds ≥ €100M
8
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, H2 2022 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €927M | 52 |
| Aug | €701M | 42 |
| Sep | €523M | 51 |
| Oct | €726M | 66 |
| Nov | €729M | 62 |
| Dec | €526M | 54 |
Top countries
by € raisedHealthtech — top countries by capital, H2 2022 — interactive chart.
Data table
| Healthtech — top countries by capital, H2 2022 | |
|---|---|
| UK | €1.2B |
| Germany | €684M |
| Switzerland | €628M |
| Sweden | €281M |
| France | €272M |
| Denmark | €218M |
| Belgium | €215M |
| Spain | €156M |
Stage mix
by € raisedHealthtech — stage mix, H2 2022 — interactive chart.
Data table
| Healthtech — stage mix, H2 2022 | |
|---|---|
| Other | €1.7B |
| Series A | €747M |
| Debt | €624M |
| Series B | €519M |
| Seed | €212M |
| Series D+ | €146M |
| Series C | €137M |
| Grant | €45M |
| Pre-Seed | €18M |
| Growth/Late | €16M |
| Crowdfunding | €3.0M |
| Early VC | €2.5M |
Top deals
largest disclosed rounds in H2 2022| Company | Stage | Date | Amount |
|---|---|---|---|
| CompuGroup Medical | Debt | Jul 2022 | €200M |
| Cera | Other | Aug 2022 | €157M |
| Cera | Debt | Aug 2022 | €157M |
| Kry | Other | Jul 2022 | €157M |
| Vectivbio | Other | Oct 2022 | €127M |
| Novaremed | Other | Jul 2022 | €127M |
| TauRx Pharmaceuticals | Other | Nov 2022 | €115M |
| Demant AS | Debt | Nov 2022 | €115M |
| Kerecis | Series D+ | Jul 2022 | €99M |
| Osler Diagnostics | Series C | Nov 2022 | €85M |
| Sparingvision | Series B | Sep 2022 | €75M |
| Resolve Biosciences | Series B | Oct 2022 | €72M |
| Pheon Therapeutics | Series A | Sep 2022 | €71M |
| F2G | Other | Aug 2022 | €69M |
| Replay | Seed | Jul 2022 | €54M |
Top investors
most active in H2 2022, by deal count- Bpifrance9 deals
- EIC Accelerator9 deals
- Calm Storm Ventures6 deals
- European Investment Bank (EIB)6 deals
- High-Tech Gründerfonds (HTGF)5 deals
- Sofinnova Partners5 deals
- Speedinvest5 deals
- Verve Ventures5 deals
- Capital Cell4 deals
- Forbion4 deals